Dan Musat, MD
Clinical Cardiac Electrophysiology · Ridgewood, NJNPI 1972767192
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (33.5%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 22.2%.
Across 225 payments — averaging $122.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$6K
- Medtronic$5K
- Baylis Medical Company Inc$4K
- Altathera Pharmaceuticals LLC$3K
- Philips North America LLC$2K
- Abbott$1K
- plus $5K from 18 others
Across 68 payments — averaging $4310.69 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Atricure, Inc.$174K
- Janssen Research & Development, LLC$84K
- Medtronic$36K
What the payments were for
- Consulting fees$8,41531%
- Speaking & faculty fees$1,4005%
- Travel & lodging$8,21930%
- Food & beverage$9,20634%
- Education$2131%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 81 | $6,105 |
| Medtronic(2 entities) | 44 | $5,377 |
| Baylis Medical Company Inc | 5 | $4,009 |
| Altathera Pharmaceuticals LLC | 5 | $2,846 |
| Philips North America LLC | 5 | $2,425 |
| Abbott | 16 | $1,486 |
| Janssen Research & Development, LLC | 11 | $1,311 |
| ZOLL Respicardia, Inc. | 1 | $879 |
| Cardiva Medical, Inc. | 9 | $669 |
| Biosense Webster, Inc. | 7 | $569 |
| Sentiar, Inc. | 1 | $500 |
| Preventice Services, LLC | 1 | $390 |
| Acutus Medical, Inc. | 1 | $193 |
| Abiomed | 10 | $191 |
| Irhythm Technologies, Inc. | 7 | $115 |
| AstraZeneca | 1 | $78 |
| Johnson & Johnson | 6 | $75 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 4 | $54 |
| Novartis | 3 | $47 |
| E.r. Squibb & Sons, L.L.C. | 3 | $40 |
| Inspire Medical Systems, Inc. | 1 | $28 |
| Amgen | 1 | $27 |
| Sanofi-aventis U.S. LLC | 1 | $20 |
| Pfizer | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Sotalol Hydrochloride$2,797
- IGT D Peripheral$2,000
- NRG needle$1,417
- RHYTHMIA$1,122
- GENERAL - THERAPIES$981
- EVERA MRI XT DR SURESCAN$924
- remede System$879
- AVEIR$853
- Vascular Closure Device$500
- CommandEP$500
- BG Mini Plus$390
- Watchman$358
- COBALT DR MRI SURESCAN$333
- Reveal LINQ$300
- Rhythmia Mapping System$293
- Micra$276
- Carto 3$265
- Farapulse$173
- AURORA EV-ICD MRI SURESCAN$171
- LINQ II$161
How this compares
$27,453 in reported general payments places this provider in the 70th percentile of 102 clinical cardiac electrophysiology providers in New Jersey.
See all clinical cardiac electrophysiology providers in New Jersey →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 140 | $134,421 |
| XareltoRivaroxaban | 37 | $47,489 |
| MultaqDronedarone Hcl | 31 | $39,792 |
| Dofetilide | 11 | $2,666 |
| Metoprolol Succinate | 107 | $2,072 |
| Ranolazine ErRanolazine | 18 | $1,577 |
| Amiodarone Hcl | 48 | $1,498 |
| Bisoprolol Fumarate | 20 | $606 |
| Spironolactone | 13 | $286 |
| Carvedilol | 12 | $78 |
| Pantoprazole Sodium | 12 | $32 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $18 | $134,421140 claims |
| Johnson & JohnsonXarelto | $75 | $47,48937 claims |
| Sanofi-aventis U.S. LLCMultaq | $20 | $39,79231 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 102 clinical cardiac electrophysiology providers in New Jersey.
Other clinical cardiac electrophysiology in Ridgewood
- Jonathan SteinbergRidgewood$85K
- Benjamin D SouzaCherry Hill$741K
- Suneet MittalParamus$722K
- George MarkHaddon Heights$312K
- Raffaele CorbisieroBrowns Mills$135K
- Emad AzizNewark$112K
- Marc RoelkeWest Orange$110K
- Arjun TheerthamParlin$102K
- Michael LinkGalloway$96K
- Grant SimonsEnglewood$93K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.